Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Dihydrolipoic acid as an ophthalmological agent to suppress intolerance reactions in the area between implants and living body tissue

Dihydrolipoic acid as an ophthalmological agent to suppress intolerance reactions in the area between implants and living body tissue

US Patent 5691379 · Granted Nov 25, 1997

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Use of R-(+)-.alpha.-lipoic acid, R-(-)-dihydrolipoic acid and metabolites in th2001
Pharmaceutical compositions containing R-.alpha.-lipoic acid or S-.alpha.-lipoic2001
Use of aminoadamantane compounds as immunoregulators2001
Use of aminoadamantane compounds as immunoregulators2001
Use of flupirtine for the prophylaxis and therapy of disorders which are associa2000
Use of R-(+)-.alpha.-lipoic acid, R-(-)-dihydrolipoic acid and metabolites in th2000
Non-alcoholic beverage and process of making2000
Use of R-(+)-.alpha.-lipoic acid, R-(-)-dihydrolipoic acid and metabolites in th1999
Method of increasing viability of stored erythrocytes by addition of lipoic, dih1998
Pharmaceutical composition containing R-.alpha.-lipoic acid or S-.alpha.-lipoic 1998
Primary and secondary neuroprotective effect of flupirtine in neurodegenerative 1998
Use of R-(+)-.alpha.-lipoic acid, R-(-)dihydrolipoic acid and metabolites in the1997